incurable hand disease]
By Asian News International | Asian News International, Washington Dc
UPDATED ON JUL 08, 2018 03:46 PM IST
Researchers found that an injection of the anti- Tumour Necrosis Factor (TNF) drug adalimumab into Dupuytren’s disease nodules results in reduction of the cell characteristics responsible for its growth.
Enter your email to get our daily newsletter in your inbox
Get our daily newsletter in your inbox
Thank you for subscribing to our daily newsletter.